Pricing
Login
Home
Charts
Search
Watchlist
Products

Sat Kartar Life Ltd

SATKARTAR
₹150.00-4.37%20 Nov 2026
Reports
Pharma Formulations

Sat Kartar Life Ltd

SATKARTAR
₹150.00
-4.37%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹237Cr
Close
Close Price
₹150.00
Industry
Industry
Pharma Formulations
PE
Price To Earnings
12.40
PS
Price To Sales
1.06
Revenue
Revenue
₹224Cr
Rev Gr TTM
Revenue Growth TTM
26.69%
PAT Gr TTM
PAT Growth TTM
43.34%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2024Mar 2025Sep 2025Mar 2026Sep 2026
Revenue
RevenueCr
768790111114
Growth YoY
Revenue Growth YoY%
18.827.026.4
Expenses
ExpensesCr
7079809699
Operating Profit
Operating ProfitCr
69101515
OPM
OPM%
7.49.910.913.412.7
Other Income
Other IncomeCr
01210
Interest Expense
Interest ExpenseCr
00000
Depreciation
DepreciationCr
11122
PBT
PBTCr
69111515
Tax
TaxCr
12333
PAT
PATCr
467109
Growth YoY
PAT Growth YoY%
91.163.626.7
NPM
NPM%
5.06.98.18.98.1
EPS
EPS₹
2.44.54.66.25.9
QuarterSep 2024Mar 2025Sep 2025Mar 2026Sep 2026
Revenue
RevenueCr
768790111114
Growth YoY
Revenue Growth YoY%
18.827.026.4
Expenses
ExpensesCr
7079809699
Operating Profit
Operating ProfitCr
69101515
OPM
OPM%
7.49.910.913.412.7
Other Income
Other IncomeCr
01210
Interest Expense
Interest ExpenseCr
00000
Depreciation
DepreciationCr
11122
PBT
PBTCr
69111515
Tax
TaxCr
12333
PAT
PATCr
467109
Growth YoY
PAT Growth YoY%
91.163.626.7
NPM
NPM%
5.06.98.18.98.1
EPS
EPS₹
2.44.54.66.25.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026TTM
Revenue
RevenueCr
163201224
Growth
Revenue Growth%
23.226.7
Expenses
ExpensesCr
149176195
Operating Profit
Operating ProfitCr
142529
OPM
OPM%
8.712.313.1
Other Income
Other IncomeCr
121
Interest Expense
Interest ExpenseCr
110
Depreciation
DepreciationCr
134
PBT
PBTCr
132330
Tax
TaxCr
367
PAT
PATCr
101719
Growth
PAT Growth%
74.243.3
NPM
NPM%
6.08.58.5
EPS
EPS₹
7.410.912.1
Financial YearMar 2025Mar 2026TTM
Revenue
RevenueCr
163201224
Growth
Revenue Growth%
23.226.7
Expenses
ExpensesCr
149176195
Operating Profit
Operating ProfitCr
142529
OPM
OPM%
8.712.313.1
Other Income
Other IncomeCr
121
Interest Expense
Interest ExpenseCr
110
Depreciation
DepreciationCr
134
PBT
PBTCr
132330
Tax
TaxCr
367
PAT
PATCr
101719
Growth
PAT Growth%
74.243.3
NPM
NPM%
6.08.58.5
EPS
EPS₹
7.410.912.1
Sales CAGR
1 Year23%
3 Years-
5 Years-
TTM-
EBITDA CAGR
1 Year74%
3 Years-
5 Years-
TTM-
PAT CAGR
1 Year74%
3 Years-
5 Years-
TTM-
Avg. ROCE
1 Year34%
3 Years-
5 Years-
TTM39%
CFO / EBITDA
1 Year2%
3 Years-
5 Years-
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
161616
Reserves
ReservesCr
365260
Current Liabilities
Current LiabilitiesCr
1116
Non Current Liabilities
Non Current LiabilitiesCr
22
Total Liabilities
Total LiabilitiesCr
6585103
Current Assets
Current AssetsCr
5669
Non Current Assets
Non Current AssetsCr
915
Total Assets
Total AssetsCr
6585103
Financial YearMar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
161616
Reserves
ReservesCr
365260
Current Liabilities
Current LiabilitiesCr
1116
Non Current Liabilities
Non Current LiabilitiesCr
22
Total Liabilities
Total LiabilitiesCr
6585103
Current Assets
Current AssetsCr
5669
Non Current Assets
Non Current AssetsCr
915
Total Assets
Total AssetsCr
6585103

Cash Flow

Consolidated
Standalone
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-50
Investing Cash Flow
Investing Cash FlowCr
0-9
Financing Cash Flow
Financing Cash FlowCr
34-1
Net Cash Flow
Net Cash FlowCr
28-9
Free Cash Flow
Free Cash FlowCr
-10-7
CFO To PAT
CFO To PAT%
-51.62.8
CFO To EBITDA
CFO To EBITDA%
-35.61.9
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-50
Investing Cash Flow
Investing Cash FlowCr
0-9
Financing Cash Flow
Financing Cash FlowCr
34-1
Net Cash Flow
Net Cash FlowCr
28-9
Free Cash Flow
Free Cash FlowCr
-10-7
CFO To PAT
CFO To PAT%
-51.62.8
CFO To EBITDA
CFO To EBITDA%
-35.61.9

Ratios

Consolidated
Standalone
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
239237237
Price To Earnings
Price To Earnings
24.413.812.4
Price To Sales
Price To Sales
1.51.21.1
Price To Book
Price To Book
4.73.53.5
EV To EBITDA
EV To EBITDA
15.18.87.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
92.691.291.2
OPM
OPM%
8.712.313.1
NPM
NPM%
6.08.58.5
ROCE
ROCE%
23.833.939.2
ROE
ROE%
19.125.325.3
ROA
ROA%
15.120.218.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
239237237
Price To Earnings
Price To Earnings
24.413.812.4
Price To Sales
Price To Sales
1.51.21.1
Price To Book
Price To Book
4.73.53.5
EV To EBITDA
EV To EBITDA
15.18.87.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
92.691.291.2
OPM
OPM%
8.712.313.1
NPM
NPM%
6.08.58.5
ROCE
ROCE%
23.833.939.2
ROE
ROE%
19.125.325.3
ROA
ROA%
15.120.218.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr402338243237233233232
Close PriceClose₹285.9093.41680.10150.0038.16404.00320.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE32.1611.1112.4020.4528.93
Price To SalesPS1.912.322.131.065.752.294.73
RevenueRevenueCr2101451142244110149
Revenue Growth TTMRev Gr TTM%27.5%6.1%28.2%26.7%-8.4%41.8%96.6%
PAT Growth TTMPAT Gr TTM%41.9%-294.4%26.1%43.3%-238.4%16.6%83.2%
Market CapitalizationMkt CapCr402338243237233233232
Close PriceClose₹285.9093.41680.10150.0038.16404.00320.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE32.1611.1112.4020.4528.93
Price To SalesPS1.912.322.131.065.752.294.73
RevenueRevenueCr2101451142244110149
Revenue Growth TTMRev Gr TTM%27.5%6.1%28.2%26.7%-8.4%41.8%96.6%
PAT Growth TTMPAT Gr TTM%41.9%-294.4%26.1%43.3%-238.4%16.6%83.2%
Annual Reports
Quarterly Reports
Load More
Interviews